Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules

Launched by GUANGDONG PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE · Dec 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called ShenJu Granules in patients who have high cholesterol (known as hyperlipidemia) and a condition where the arteries in the neck become narrowed or hardened (called carotid atherosclerosis). The main goal is to see how well this treatment works and how safe it is. Researchers want to gather information that could support the use of traditional Chinese medicine for these conditions.

To participate in this study, individuals must be between 18 and 65 years old and have been diagnosed with both high cholesterol and carotid artery issues. They should also be able to sign a consent form to show they understand the study. However, those with serious health problems, such as severe heart or kidney conditions, or who are pregnant or breastfeeding, cannot join the trial. Participants can expect to receive the treatment while being closely monitored by healthcare professionals to ensure their safety throughout the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The patient has informed consent and signed the informed consent form
• • 2. Age between 18-65 years old
• • 3. Meet the diagnostic criteria for hyperlipidemia and accompanied by carotid arteriosclerosis
• • 4. Meet the diagnostic criteria of TCM wet certificate: refer to the scoring standard of TCM Wet Disease Scale
• Exclusion Criteria:
• • 1. Severe liver, kidney and cardiac insufficiency
• • 2. Any other serious disease or condition such as: malignant tumor, uncontrolled severe hypertension, diabetic ketoacidosis (acute complication/vascular abnormality), arrhythmia, coagulation abnormalities
• • 3. Have participated in another clinical study within 30 days prior to enrollment or have received a history of randomized ketoacidosis in this study
• • 4. Pregnant women, women preparing to become pregnant and lactating women
• • 5. Patients who are allergic to relevant Chinese medicine ingredients
• • 6. Patients who have had a stent inserted
• • 7. Patients who the investigator determines are not suitable to participate in this study